Login Register Cart 0
Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Review Article

The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer

Author(s): Vladimir Stanislavovich Rogovskii*

Volume 17, Issue 4, 2017

Page: [325 - 332] Pages: 8

DOI: 10.2174/1568009617666170109110816

Price: $65

Abstract

Background: It is widely accepted that chronic inflammation critically contributes to cancer. Immune tolerance in cancer mediates tumor escape from the immune system. The mechanisms of relations between inflammation and immune tolerance are still not fully elucidated.

Objective: The main mechanisms that link inflammation and tolerance are considered. Drug targets that are in use to interfere with inflammation in cancer are discussed.

Conclusion: Inflammation mediates tumor-induced tolerance. The induction and the maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.

Keywords: Inflammation, resolution, immune tolerance, cancer immunotherapy, tumor immunology, tumor-induced tolerance.

« Previous Next »
Graphical Abstract


Rights & Permissions Print Export Cite as
Article Metrics
69
10
1
© 2023 Bentham Science Publishers | Privacy Policy